RU2003107768A - TREATMENT MEMBRANE-CONTROLLED BANDAGE - Google Patents

TREATMENT MEMBRANE-CONTROLLED BANDAGE

Info

Publication number
RU2003107768A
RU2003107768A RU2003107768/14A RU2003107768A RU2003107768A RU 2003107768 A RU2003107768 A RU 2003107768A RU 2003107768/14 A RU2003107768/14 A RU 2003107768/14A RU 2003107768 A RU2003107768 A RU 2003107768A RU 2003107768 A RU2003107768 A RU 2003107768A
Authority
RU
Russia
Prior art keywords
controlled
bandage
membrane
treatment membrane
molecular weight
Prior art date
Application number
RU2003107768/14A
Other languages
Russian (ru)
Other versions
RU2233674C1 (en
Inventor
Юрий Семенович Винник
Сергей Владимирович Якимов
Геворк Эдуардович Карапетян
Георгий Михайлович Сычев
Игорь Николаевич Большаков
Original Assignee
Красноярская государственная медицинская академия
Filing date
Publication date
Application filed by Красноярская государственная медицинская академия filed Critical Красноярская государственная медицинская академия
Priority to RU2003107768/14A priority Critical patent/RU2233674C1/en
Priority claimed from RU2003107768/14A external-priority patent/RU2233674C1/en
Application granted granted Critical
Publication of RU2233674C1 publication Critical patent/RU2233674C1/en
Publication of RU2003107768A publication Critical patent/RU2003107768A/en

Links

Claims (1)

Лечебная мембранно-контролируемая повязка, включающая замкнутую полость со стенками из полупроницаемой мембраны, заполненную гелем и лекарственными веществами, отличающаяся тем, что в качестве полупроницаемой мембраны используют трубчатую ацетат-целлюлозную мембрану фирмы Sigma с наружным диаметром 2,7 см, имеющей диаметр пор 2,5-2,8 нм, пропускающих вещества до 10000 Д, содержащую ксерогель органической соли хитозана с молекулярной массой 10000 Д, и лекарственный состав включает медикаменты молекулярной массой до 5000 Д.Therapeutic membrane-controlled dressing, including a closed cavity with walls of a semipermeable membrane, filled with gel and medicinal substances, characterized in that as a semipermeable membrane using a tubular acetate-cellulose membrane company Sigma with an outer diameter of 2.7 cm, having a pore diameter of 2, 5-2.8 nm, passing substances up to 10,000 D, containing the xerogel of an organic salt of chitosan with a molecular weight of 10,000 D, and the pharmaceutical composition includes medicines with a molecular weight of up to 5,000 D.
RU2003107768/14A 2003-03-20 2003-03-20 Membrane-controlled salve dressing RU2233674C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2003107768/14A RU2233674C1 (en) 2003-03-20 2003-03-20 Membrane-controlled salve dressing

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2003107768/14A RU2233674C1 (en) 2003-03-20 2003-03-20 Membrane-controlled salve dressing

Publications (2)

Publication Number Publication Date
RU2233674C1 RU2233674C1 (en) 2004-08-10
RU2003107768A true RU2003107768A (en) 2004-09-10

Family

ID=33414156

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003107768/14A RU2233674C1 (en) 2003-03-20 2003-03-20 Membrane-controlled salve dressing

Country Status (1)

Country Link
RU (1) RU2233674C1 (en)

Similar Documents

Publication Publication Date Title
RU2350333C3 (en) Application of ivermectin for the treatment of dermatologic disorders
WO2006048829A3 (en) Preparation of chitin and derivatives thereof for cosmetic and therapeutic use
BR112013003677A2 (en) use of pharmacologically active agent and pharmaceutical dosage form
ATE410424T1 (en) SPIROCYCLIC CYCLOHEXANE DERIVATIVES
EA200800798A1 (en) PHARMACEUTICAL COMPOSITIONS INTENDED FOR THE TREATMENT OF DISTURBANCES OF THE INTERNAL EAR
BRPI0707612B8 (en) sealed vessel and liquid formulations contained therein
DK1654253T3 (en) Substituted 3-pyrrolidine indole derivatives
RS54438B1 (en) Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
ATE412635T1 (en) DIPHENYLPYRIDINE DERIVATIVES, THEIR PRODUCTION AND THEIR THERAPEUTIC USE
DE60307632D1 (en) PIPERAZINYLACYLPIPERIDIN DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
NO20055601D0 (en) Pharmaceutical preparation in the form of a hydrogel for transdermal administration of active ingredients
ZA200606679B (en) Furosemide derivatives as modulators of HM74 and their use for the treatment of inflammation
WO2005079750A3 (en) Films for use as dosage forms
ATE474840T1 (en) 6-HETEROARYLPYRIDOINDOLONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
RU2003107768A (en) TREATMENT MEMBRANE-CONTROLLED BANDAGE
FR2855721B1 (en) ANTISEPTIC MICROBICIDE, AND COSMETIC, MEDICINAL PRODUCT AND FOOD INCLUDING THE ANTISEPTIC MICROBICIDE
ES2602179T3 (en) A wound care device
FR2857222B1 (en) ANTISEPTIC MICROBICIDE, AND COSMETIC, MEDICINAL PRODUCT AND FOOD INCLUDING THE ANTISEPTIC MICROBICIDE
RU2007116477A (en) METHOD FOR TREATMENT OF BACTERIAL PURULENT MENITITIS IN CHILDREN
ATE413171T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ASCORBIC ACID FOR THE TREATMENT OF FUNGAL SUPERINFECTIONS AND FUNGAL RECUPS
NL1022442C2 (en) Use of lipid to improve the absorption of nutrients and (pharmaceutically) active substances.
EA200701525A1 (en) PHARMACEUTICAL POLYMERIC COMPOSITION FOR ORAL ADMINISTRATION OF TERBUTALINE SULFATE WITH CONTROLLED DELIVERY
EP2082751A3 (en) Topical formulations in the form of aqueous gels fro the treatment of disorders of the skin and mucous membranes or as vehicules for transdermal administration of natural extractive preparations, substances, molecules and drugs
DE602006021594D1 (en) CONNECTION TO THE PREVENTION AND TREATMENT OF LEFT
RU2233674C1 (en) Membrane-controlled salve dressing